Siddharth Singh

Siddharth Singh

University of California, San Diego

H-index: 90

North America-United States

About Siddharth Singh

Siddharth Singh, With an exceptional h-index of 90 and a recent h-index of 76 (since 2020), a distinguished researcher at University of California, San Diego, specializes in the field of Comparative Effectiveness Research, Inflammatory Bowel Diseases, Chronic Liver Disease, Cancer Prevention.

His recent articles reflect a diverse array of research interests and contributions to the field:

Modeling endoscopic improvement after induction treatment with mesalamine in patients with mild-to-moderate ulcerative colitis

Increased risk of infections with anti-TNF agents in patients with Crohn’s disease after elective surgery: meta-analysis

Comparative risk of serious infections with tumor necrosis factor α antagonists vs vedolizumab in patients with inflammatory bowel diseases

Magnitude and time-trend analysis of postendoscopy esophageal adenocarcinoma: a systematic review and meta-analysis

Spatial evolution of histologic and endoscopic healing in the left and right colon in patients with ulcerative colitis

Early Combined Immunosuppression Reduces Complications in Long-standing Crohn's Disease: A Post Hoc Analysis of REACT

Trends in US health care spending on inflammatory bowel diseases, 1996-2016

Comparative safety and effectiveness of vedolizumab to tumor necrosis factor antagonist therapy for ulcerative colitis

Siddharth Singh Information

University

Position

Gastroenterology; Clinical Informatics

Citations(all)

29686

Citations(since 2020)

21966

Cited By

50648

hIndex(all)

90

hIndex(since 2020)

76

i10Index(all)

243

i10Index(since 2020)

226

Email

University Profile Page

University of California, San Diego

Google Scholar

View Google Scholar Profile

Siddharth Singh Skills & Research Interests

Comparative Effectiveness Research

Inflammatory Bowel Diseases

Chronic Liver Disease

Cancer Prevention

Top articles of Siddharth Singh

Title

Journal

Author(s)

Publication Date

Modeling endoscopic improvement after induction treatment with mesalamine in patients with mild-to-moderate ulcerative colitis

Clinical Gastroenterology and Hepatology

Christopher Ma

Jenny Jeyarajah

Leonardo Guizzetti

Claire E Parker

Siddharth Singh

...

2022/2/1

Increased risk of infections with anti-TNF agents in patients with Crohn’s disease after elective surgery: meta-analysis

Digestive Diseases and Sciences

Jurij Hanzel

Ahmed Almradi

Alexandra C Istl

Mei Lucy Yang

Katherine A Fleshner

...

2022/2/1

Comparative risk of serious infections with tumor necrosis factor α antagonists vs vedolizumab in patients with inflammatory bowel diseases

Clinical Gastroenterology and Hepatology

Siddharth Singh

Herbert C Heien

Jeph Herrin

Parambir S Dulai

Lindsey Sangaralingham

...

2022/2/1

Magnitude and time-trend analysis of postendoscopy esophageal adenocarcinoma: a systematic review and meta-analysis

Tarek Sawas

Abdul Mounaem Majzoub

James Haddad

Thomas Tielleman

Tarek Nayfeh

...

2022/2/1

Spatial evolution of histologic and endoscopic healing in the left and right colon in patients with ulcerative colitis

Clinical Gastroenterology and Hepatology

Sushrut Jangi

Ariela K Holmer

Parambir S Dulai

Brigid Boland

Mark Valasek

...

2022/4/1

Early Combined Immunosuppression Reduces Complications in Long-standing Crohn's Disease: A Post Hoc Analysis of REACT

Clinical Gastroenterology and Hepatology

Jurij Hanzel

Christopher Ma

Guangyong Zou

Siddharth Singh

Parambir S Dulai

...

2022/1/1

Trends in US health care spending on inflammatory bowel diseases, 1996-2016

Inflammatory Bowel Diseases

Siddharth Singh

Alexander S Qian

Nghia H Nguyen

Stephanie KM Ho

Jiyu Luo

...

2022/3/1

Comparative safety and effectiveness of vedolizumab to tumor necrosis factor antagonist therapy for ulcerative colitis

Clinical Gastroenterology and Hepatology

Dana Lukin

David Faleck

Ronghui Xu

Yiran Zhang

Aaron Weiss

...

2022/1/1

Risk of relapse in patients with ulcerative colitis with persistent endoscopic healing: a durable treatment endpoint

Journal of Crohn's and Colitis

Sushrut Jangi

Ariela K Holmer

Parambir S Dulai

Brigid S Boland

Angelina E Collins

...

2021/4/1

Early combined immunosuppression may be more effective for reducing complications in isolated colonic-vs ileal-dominant Crohn disease

Inflammatory bowel diseases

Parambir S Dulai

Vipul Jairath

Guangyong Zou

Larry W Stitt

Reena Khanna

...

2021/5/1

Medical Management Following Surgical Therapy in Inflammatory Bowel Disease: Evidence from Cochrane Reviews

Nilesh Chande

Siddharth Singh

Neeraj Narula

Morris Gordon

M Ellen Kuenzig

...

2021/9/1

AGA technical review on the medical management of moderate to severe luminal and perianal fistulizing Crohn’s disease

Siddharth Singh

Deborah Proctor

Frank I Scott

Yngve Falck-Ytter

Joseph D Feuerstein

2021/6/1

Paternal exposure to immunosuppressive and/or biologic agents and birth outcomes in patients with immune-mediated inflammatory diseases

Gastroenterology

Joseph Meserve

Jiyu Luo

Wenhong Zhu

Nina Veeravalli

Gretchen Bandoli

...

2021/7/1

Change in MRI-PDFF and histologic response in patients with nonalcoholic steatohepatitis: a systematic review and meta-analysis

Jonathan G Stine

Nagambika Munaganuru

Abbey Barnard

Jennifer L Wang

Kellee Kaulback

...

2021/11/1

Comparative effectiveness of entecavir versus tenofovir for preventing hepatocellular carcinoma in patients with chronic hepatitis B: a systematic review and meta‐analysis

Shravan Dave

Sooyoung Park

M Hassan Murad

Abbey Barnard

Larry Prokop

...

2021/1

Gender disparities in food security, dietary intake, and nutritional health in the United States

Official journal of the American College of Gastroenterology| ACG

Christopher Ma

Stephanie KM Ho

Siddharth Singh

May Y Choi

2021/3/1

Correction to: Understanding Determinants of Patient Preferences Between Stool Tests and Colonoscopy for the Assessment of Disease Activity in Inflammatory Bowel Disease

Digestive diseases and sciences

Maria Barsky

Joseph Meserve

Helen Le

Angelina Collins

Siddharth Singh

...

2021/9/1

Gastrointestinal surgery for inflammatory bowel disease persistently lowers microbiome and metabolome diversity

INFLAMMATORY BOWEL DISEASES

Xin Fang

Yoshiki Vazquez-Baeza

Emmanuel Elijah

Fernando Vargas

Gail Ackermann

...

2021/8/1

AGA clinical practice guidelines on the medical management of moderate to severe luminal and perianal fistulizing Crohn’s disease

Gastroenterology

Joseph D Feuerstein

Edith Y Ho

Eugenia Shmidt

Harminder Singh

Yngve Falck-Ytter

...

2021/6/1

Burden and outcomes of fragmentation of care in hospitalized patients with inflammatory bowel diseases: a nationally representative cohort

Inflammatory Bowel Diseases

Nghia H Nguyen

Jiyu Luo

Lucila Ohno-Machado

William J Sandborn

Siddharth Singh

2021/7/1

See List of Professors in Siddharth Singh University(University of California, San Diego)

Co-Authors

H-index: 198
William Sandborn

William Sandborn

University of California, San Diego

H-index: 149
Hashem B El-Serag

Hashem B El-Serag

Baylor College of Medicine

H-index: 125
Rohit Loomba, MD, MHSc

Rohit Loomba, MD, MHSc

University of California, San Diego

H-index: 50
Parambir S. Dulai

Parambir S. Dulai

University of California, San Diego

H-index: 43
Rohan Khera

Rohan Khera

Yale University

academic-engine